Literature DB >> 9003387

Cross-linking of the high-affinity IgE receptor induces the expression of cyclo-oxygenase 2 and attendant prostaglandin generation requiring interleukin 10 and interleukin 1 beta in mouse cultured mast cells.

M Ashraf1, M Murakami, I Kudo.   

Abstract

When mouse bone marrow-derived mast cells (BMMC) developed in interleukin (IL)-3 were activated with IgE and antigen (IgE/antigen) in the presence of both IL-10 and IL-1 beta, two sequential phases of prostaglandin (PG)D2 generation were elicited, in which the first phase occurred by 1 h and the second phase from 2 to 10 h. The delayed phase of PGD2 generation was accompanied by a marked induction of cyclo-oxygenase (COX)-2 mRNA, which reached a peak at 1-2 h, followed by that of its protein from 2-10 h, with a peak at 5 h. The immediate phase of PGD2 generation was completely abrogated by the irreversible inhibition of pre-existing COX-1 by aspirin pretreatment, whereas the delayed phase of PGD2 generation was almost undetectable in the presence of the COX-2 inhibitor NS-398. A detailed analysis of the individual effects of IgE/antigen, IL-10 and IL-1 beta on COX-2 expression revealed that IgE/antigen and IL-10 each initiated and stabilized COX-2 mRNA expression, leading to an increase in the expression of its protein. Conversely, IL-1 beta stabilized the COX-2 protein without affecting its mRNA level. The induction of COX-2 by IgE/antigen with IL-10 and IL-1 beta preceded the induction of transcripts for endogenous cytokines such as IL-6, IL-1 beta and IL-10. The inhibition of PGD2 generation by indomethacin did not affect the induction of COX-2 or these cytokines. Thus the two major delayed-phase responses of BMMC after IgE-dependent activation, namely COX-2-dependent PGD2 generation and cytokine production, are regulated independently.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003387      PMCID: PMC1218022          DOI: 10.1042/bj3200965

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  67 in total

Review 1.  Recent advances in the cellular and molecular biology of mast cells.

Authors:  R L Stevens; K F Austen
Journal:  Immunol Today       Date:  1989-11

2.  Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Authors:  L Hültner; C Druez; J Moeller; C Uyttenhove; E Schmitt; E Rüde; P Dörmer; J Van Snick
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

3.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

4.  Human mast cells derived from fetal liver cells cultured with stem cell factor express a functional CD51/CD61 (alpha v beta 3) integrin.

Authors:  Y Shimizu; A M Irani; E J Brown; L K Ashman; L B Schwartz
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

5.  NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

Authors:  N Futaki; K Yoshikawa; Y Hamasaka; I Arai; S Higuchi; H Iizuka; S Otomo
Journal:  Gen Pharmacol       Date:  1993-01

6.  Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

Authors:  B S Fletcher; D A Kujubu; D M Perrin; H R Herschman
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

7.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

8.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01

9.  Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.

Authors:  J M Mencia-Huerta; R A Lewis; E Razin; K F Austen
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

10.  Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4.

Authors:  J W Coleman; M R Holliday; I Kimber; K M Zsebo; S J Galli
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

View more
  7 in total

1.  IgE, COX-2, and IL-4 are expressed by DEHP through p38 MAPK and suppressed by plant glycoprotein (75 kDa) in ICR mice.

Authors:  Phil-Sun Oh; Kye-Taek Lim
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

2.  Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK.

Authors:  W W Lin; B C Chen
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Saucerneol F, a New Lignan Isolated from Saururus chinensis, Attenuates Degranulation via Phospholipase Cγ 1 Inhibition and Eicosanoid Generation by Suppressing MAP Kinases in Mast Cells.

Authors:  Yue Lu; Jong-Keun Son; Hyeun Wook Chang
Journal:  Biomol Ther (Seoul)       Date:  2012-11       Impact factor: 4.634

4.  Ginsenoside F1 Attenuates Eosinophilic Inflammation in Chronic Rhinosinusitis by Promoting NK Cell Function.

Authors:  So Jeong Kim; Jinju Lee; Woo Sun Choi; Hyo Jeong Kim; Mi-Yeon Kim; Sun Chang Kim; Hun Sik Kim
Journal:  J Ginseng Res       Date:  2021-03-29       Impact factor: 6.060

5.  Sweet taste receptor agonists attenuate macrophage IL-1β expression and eosinophilic inflammation linked to autophagy deficiency in myeloid cells.

Authors:  Jinju Lee; So Jeong Kim; Go Eun Choi; Eunbi Yi; Hyo Jin Park; Woo Seon Choi; Yong Ju Jang; Hun Sik Kim
Journal:  Clin Transl Med       Date:  2022-08

6.  Curcumin inhibits the activation of immunoglobulin e-mediated mast cells and passive systemic anaphylaxis in mice by reducing serum eicosanoid and histamine levels.

Authors:  Xian Li; Yue Lu; Ye Jin; Jong-Keun Son; Seung Ho Lee; Hyeun Wook Chang
Journal:  Biomol Ther (Seoul)       Date:  2014-01       Impact factor: 4.634

7.  Endothelial Regulator of Calcineurin 1 Promotes Barrier Integrity and Modulates Histamine-Induced Barrier Dysfunction in Anaphylaxis.

Authors:  Constanza Ballesteros-Martinez; Nerea Mendez-Barbero; Alma Montalvo-Yuste; Bettina M Jensen; Aída Gomez-Cardenosa; Lotte Klitfod; María Garrido-Arandia; Gloria Alvarez-Llamas; Carlos Pastor-Vargas; Fernando Vivanco; Lene Heise Garvey; Javier Cuesta-Herranz; Lars K Poulsen; Vanesa Esteban
Journal:  Front Immunol       Date:  2017-10-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.